In recent years, the United Kingdom has witnessed a marked increase in the prescription of cannabis-based medicinal products (CBMPs). Approved for conditions such as chronic pain, epilepsy, and multiple sclerosis, these products represent a significant shift in how healthcare providers approach complex, long-term health conditions. However, alongside this medical evolution comes an important legal and…